Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-363.39M
↓ 168% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-135.54M
Historical baseline
PeriodValueYoY Change
2025$-363.39M-21.5%
2024$-299.04M-17.5%
2023$-254.45M-89.5%
2022$-134.30M-68.5%
2021$-79.73M+27.8%
2020$-110.38M-162.9%
2019$-41.98M-26.9%
2018$-33.08M-24.7%
2017$-26.53M-112.1%
2016$-12.51M-